{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-054940","form_type":"8-K","ticker":"MRKR","cik":"0001094038","company_name":"Marker Therapeutics, Inc.","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.942447+00:00","generated_at":"2026-05-14T23:49:23.006117+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"confidence":"high","headline":"Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M","bullets":["Shareholders approved Charter Amendment to increase authorized common stock from 30M to 130M shares (10.9M for, 1.4M against).","Proposal to revise voting threshold for share changes failed; broker non-votes prevented passage.","All five director nominees re-elected; advisory vote on executive compensation passed.","Ratification of CBIZ CPAs as independent auditor for fiscal 2026 approved by shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-054940","json":"https://secwatch.observer/filing/0001104659-26-054940.json","markdown":"https://secwatch.observer/filing/0001104659-26-054940.md","text":"https://secwatch.observer/filing/0001104659-26-054940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/0001104659-26-054940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/tm2613511d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:49:23.006117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}